tradingkey.logo
tradingkey.logo
Search

Dr Reddy's Laboratories Ltd

RDY
Add to Watchlist
11.850USD
+0.015+0.13%
Close 07-31 16:00ETQuotes delayed by 15 min
10.03BMarket Cap
20.33P/E TTM

Dr Reddy's Laboratories Ltd

11.850
+0.015+0.13%
View Detailed Chart
TradingKey Chart
Intraday
1m
30m
1h
D
W
M
D

Today

+0.13%

5 Days

+0.51%

1 Month

-18.22%

6 Months

-11.70%

Year to Date

-15.60%

1 Year

-16.67%

Key Figures
11.800Open
11.860High
3.01MVolume
20.33P/E TTM
25.97P/E Dynamic
0.091Dividend TTM
0.36%Turnover Ratio
11.830Prev. Close
11.720Low
16.94MTurnover
14.75P/E Static
2.45P/B
0.76%Div Yield TTM
8.03%ROA
16.17052wk High
0.98Volume Ratio
668.95MNet Profit
832.69MShares
0.5828EPS TTM
0.27Beta
12.23%ROE
12.18552wk Low
1.18%Amplitude
46.52%Gross Margin
10.03BMarket Cap
-15.69Reward/Risk
1.13%Risk Rate

Key Insights

Dr Reddy's Laboratories Ltd's fundamentals are relatively stable, and its growth potential is significant.Its valuation is considered fairly valued, ranking 82 out of 155 in the Pharmaceuticals industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Hold, with the highest price target at 13.56.In the medium term, the stock price is expected to trend down.The company has shown very weak stock market performance over the past month, in line with its fundamentals and technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

Dr Reddy's Laboratories Ltd's Score

Industry at a Glance

Industry Ranking
82 / 155
Overall Ranking
174 / 4281
Industry
Pharmaceuticals

Support & Resistance

Relevant data have not been disclosed by the company yet.

Score Analysis

Current score
Previous score

Media Coverage

Last 24 hours
Coverage Level

Very Low
Very High
Neutral

Dr Reddy's Laboratories Ltd Highlights

StrengthsRisks
Dr. Reddy’s Laboratories Limited is an India-based pharmaceutical company. Its products and services are spread across its core businesses of active pharmaceutical ingredients (APIs), generics, branded generics, biosimilars and over-the-counter (OTC) pharmaceutical products. It works in the areas of gastrointestinal, cardiovascular, diabetology, oncology, pain management and dermatology. Its segments consist of Global Generics; Pharmaceutical Services and Active Ingredients (PSAI), and Others. The Global Generics segment consists of the Company's business of manufacturing and marketing prescription and over-the-counter finished pharmaceutical products ready for consumption by the patient, marketed under a brand name (branded formulations) or as generic finished dosages with therapeutic equivalence to branded formulations (generics). The Pharmaceutical Services and Active Ingredients segment consists of the Company's business of manufacturing and marketing APIs and intermediates.
High Dividend
The company is a high dividend payer, with the latest dividend payout ratio of 11.81%.
Stable Dividend
The company has regularly paid dividends over the past 5 years, with the latest dividend payout ratio of 11.81%.
Overvalued
The company’s latest PE is 20.33, at a high 3-year percentile range.
Institutional Selling
The latest institutional holdings are 117.02M shares, decreasing 7.30% quarter-over-quarter.
Held by The Vanguard
Star Investor The Vanguard holds 7.88M shares of this stock.
Higher Market Activity
The company has more investor interest, with a 20-day turnover ratio of 0.86.

Analyst Rating

Based on 4 analysts
Hold
Current Rating
13.560
Target Price
+15.31%
Upside Space

Dr Reddy's Laboratories Ltd News

More news coming soon, stay tuned...

Earnings Forecast

Analyst Rating

Based on 4 analysts
Hold
Current Rating
13.560
Target Price
+15.31%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell

Peer Comparison

160
Total
6
Median
9
Average
Company name
Ratings
Analysts
Dr Reddy's Laboratories Ltd
RDY
4
Biogen Inc
BIIB
38
Amgen Inc
AMGN
38
Eli Lilly and Co
LLY
34
AbbVie Inc
ABBV
33
Pfizer Inc
PFE
32
1
2
3
...
32

Indicators

Indicators
Sell(3)
Neutral(3)
Buy(0)
Indicators
Value
Direction
MACD(12,26,9)
-0.133
Sell
RSI(14)
33.974
Neutral
STOCH(KDJ)(9,3,3)
34.480
Neutral
ATR(14)
0.308
High Vlolatility
CCI(14)
-51.168
Neutral
Williams %R
69.182
Sell
TRIX(12,20)
-0.718
Sell
StochRSI(14)
100.000
Overbought
Moving Average
Sell(5)
Neutral(0)
Buy(1)
Indicators
Value
Direction
MA5
11.788
Buy
MA10
11.900
Sell
MA20
12.651
Sell
MA50
13.299
Sell
MA100
13.409
Sell
MA200
13.687
Sell

Financial Indicators

EPS

Relevant data have not been disclosed by the company yet.

Total revenue

Relevant data have not been disclosed by the company yet.

Dr Reddy's Laboratories Ltd Info

Dr. Reddy’s Laboratories Limited is an India-based pharmaceutical company. Its products and services are spread across its core businesses of active pharmaceutical ingredients (APIs), generics, branded generics, biosimilars and over-the-counter (OTC) pharmaceutical products. It works in the areas of gastrointestinal, cardiovascular, diabetology, oncology, pain management and dermatology. Its segments consist of Global Generics; Pharmaceutical Services and Active Ingredients (PSAI), and Others. The Global Generics segment consists of the Company's business of manufacturing and marketing prescription and over-the-counter finished pharmaceutical products ready for consumption by the patient, marketed under a brand name (branded formulations) or as generic finished dosages with therapeutic equivalence to branded formulations (generics). The Pharmaceutical Services and Active Ingredients segment consists of the Company's business of manufacturing and marketing APIs and intermediates.
Ticker SymbolRDY
CompanyDr Reddy's Laboratories Ltd
CEOAghanian (Patrick)
Websitehttps://www.drreddys.com/

Shareholders

Shareholders
Shareholders
Proportion
Robeco Institutional Asset Management B.V.
2.06%
RBC Global Asset Management (UK) Limited
1.15%
Aperio Group, LLC
1.10%
Renaissance Technologies LLC
0.99%
Aikya Investment Management Limited
0.96%
Other
93.74%

FAQs

What is the current price of Dr Reddy's Laboratories Ltd (RDY)?

The current price of Dr Reddy's Laboratories Ltd (RDY) is 11.85.

What is the symbol of Dr Reddy's Laboratories Ltd?

The ticker symbol of Dr Reddy's Laboratories Ltd is RDY.

What is the 52-week high of Dr Reddy's Laboratories Ltd?

The 52-week high of Dr Reddy's Laboratories Ltd is 16.17.

What is the 52-week low of Dr Reddy's Laboratories Ltd?

The 52-week low of Dr Reddy's Laboratories Ltd is 12.19.

What is the market capitalization of Dr Reddy's Laboratories Ltd?

The market capitalization of Dr Reddy's Laboratories Ltd is 9.87B.

Is Dr Reddy's Laboratories Ltd (RDY) currently rated as Buy, Hold, or Sell?

According to analysts, Dr Reddy's Laboratories Ltd (RDY) has an overall rating of signal_hold, with a price target of 13.56.

What is the Earnings Per Share (EPS TTM) of Dr Reddy's Laboratories Ltd (RDY)?

The Earnings Per Share (EPS TTM) of Dr Reddy's Laboratories Ltd (RDY) is 0.58.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.